# Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma

> **NCT04903678** · NA · RECRUITING · sponsor: **Eye & ENT Hospital of Fudan University** · enrollment: 18 (estimated)

## Conditions studied

- Retinoblastoma, Extraocular

## Interventions

- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT04903678
- **Lead sponsor:** Eye & ENT Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-01
- **Primary completion:** 2028-05-01
- **Final completion:** 2030-05-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903678, "Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04903678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*